Literature DB >> 8614912

Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts.

H J Barnett, M Kaste, H Meldrum, M Eliasziw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614912     DOI: 10.1161/01.str.27.4.588

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

Review 1.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Effects of various doses of aspirin on platelet activity and endothelial function.

Authors:  Takashi Furuno; Fumiyasu Yamasaki; Takeshi Yokoyama; Kyoko Sato; Takayuki Sato; Yoshinori Doi; Tetsuro Sugiura
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 3.  A benefit-risk assessment of agents used in the secondary prevention of stroke.

Authors:  Ronald S MacWalter; Colin P Shirley
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

5.  Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.

Authors:  M Chambers; J Hutton; J Gladman
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 6.  Place of drug therapy in the treatment of carotid stenosis.

Authors:  Norberto Andaluz; Mario Zuccarello
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?

Authors:  B Dalton; C Papoushek; M F Evans
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

Review 8.  Antithrombotic and thrombolytic therapy for ischemic stroke.

Authors:  Curtis Benesch
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.